Lessons learned from the FinnDiane Study: Epidemiology and metabolic risk factors for diabetic kidney disease in type 1 diabetes

Across its operational span of more than 25 years, the observational, nationwide, multicentre Finnish Diabetic Nephropathy (FinnDiane) Study has aimed to unravel mechanisms underlying diabetic kidney disease, with a special focus on its metabolic risk factors. We sought to compile key findings relating to this topic and to offer a current perspective on the natural course of diabetic kidney disease among individuals with type 1 diabetes.

• Publication year

  2024

• Venue

  Diabetic Medicine

• Publication date

  2024-09-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/dme.15431PMID 39235140PMCID 11733665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lessons learned from the FinnDiane Study: Epidemiology and metabolic risk factors for diabetic kidney disease in type 1 diabetes

  2024cited by this paper
• Double diabetes—when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition

  2024cited by this paper
• 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH).

  2023cited by this paper
• Relationship Between Abdominal Fatness and Onset and Progression of Albuminuria in Type 1 Diabetes.

  2023cited by this paper
• The many faces of hypertension in individuals with type 1 diabetes.

  2023cited by this paper
• Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational study

  2023cited by this paper
• Progression and regression of kidney disease in type 1 diabetes

  2023cited by this paper
• Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association

  2023cited by this paper
• Incidence rate patterns, cumulative incidence, and time trends for moderate and severe albuminuria in individuals diagnosed with type 1 diabetes aged 0-14 years: a population-based retrospective cohort study.

  2022cited by this paper
• KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.

  2022cited by this paper
• Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes

  2021cited by this paper
• Resistant Hypertension and Risk of Adverse Events in Individuals With Type 1 Diabetes: A Nationwide Prospective Study

  2020cited by this paper
• Waist-height ratio and waist are the best estimators of visceral fat in type 1 diabetes

  2020cited by this paper
• Body mass index and mortality in individuals with type 1 diabetes.

  2019cited by this paper
• Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.

  2019cited by this paper
• Ambulatory blood pressure and arterial stiffness in individuals with type 1 diabetes

  2018cited by this paper
• Regression of albuminuria and its association with incident cardiovascular outcomes and mortality in type 1 diabetes: the FinnDiane Study

  2018cited by this paper
• Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus

  2017cited by this paper
• Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.

  2016cited by this paper
• Nocturnal blood pressure is associated with the progression of microvascular complications and hypertension in patients with type 1 diabetes mellitus.

  2016cited by this paper
• Leisure-time physical activity and development and progression of diabetic nephropathy in type 1 diabetes: the FinnDiane Study

  2015cited by this paper
• The consequences of failure to achieve targets of guidelines for prevention and treatment of diabetic complications in patients with type 1 diabetes

  2015cited by this paper
• Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease

  2015cited by this paper
• The Presence and Consequence of Nonalbuminuric Chronic Kidney Disease in Patients With Type 1 Diabetes

  2015cited by this paper
• Diabetic kidney disease

  2015cited by this paper
• Epidemiology and risk factors for diabetic kidney disease.

  2014cited by this paper
• Antihypertensive Treatment and Resistant Hypertension in Patients With Type 1 Diabetes by Stages of Diabetic Nephropathy

  2014cited by this paper
• Triglyceride‐cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study

  2013cited by this paper
• Incidence of type 1 diabetes in Finland.

  2013cited by this paper
• The Effect of Excess Weight Gain With Intensive Diabetes Mellitus Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes Mellitus: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) Stu

  2013cited by this paper
• Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.

  2011cited by this paper
• Pulse Pressure Predicts Incident Cardiovascular Disease but Not Diabetic Nephropathy in Patients With Type 1 Diabetes (The FinnDiane Study)

  2011cited by this paper
• Depression is associated with the metabolic syndrome among patients with type 1 diabetes

  2010cited by this paper
• Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study

  2010cited by this paper
• Effect of Parental Type 2 Diabetes on Offspring With Type 1 Diabetes

  2009cited by this paper
• Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As

  2009cited by this paper
• The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes

  2009cited by this paper
• A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 Diabetes

  2009cited by this paper
• Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes

  2009cited by this paper
• Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes

  2009cited by this paper
• Arterial Hypertension Determined by Ambulatory Blood Pressure Profiles

  2008cited by this paper
• Reduction in Microalbuminuria as an Integrated Indicator for Renal and Cardiovascular Risk Reduction in Patients With Type 2 Diabetes

  2007cited by this paper
• Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.

  2007cited by this paper
• Relationship between lipid profiles and kidney function in patients with type 1 diabetes

  2007cited by this paper
• Progression of microalbuminuria in type 1 diabetes: ten-year prospective observational study.

  2005cited by this paper
• Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).

  2005cited by this paper
• Altered Age-Related Blood Pressure Pattern in Type 1 Diabetes

  2004cited by this paper
• Regression of microalbuminuria in type 1 diabetes.

  2003cited by this paper
• Statins in hypercholesterolaemia: A dose-specific meta-analysis of lipid changes in randomised, double blind trials

  2003cited by this paper
• Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study.

  2002cited by this paper
• Can clinical factors estimate insulin resistance in type 1 diabetes?

  2000cited by this paper
• Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients.

  1998cited by this paper
• Insulin resistance precedes microalbuminuria in patients with insulin-dependent diabetes mellitus.

  1998cited by this paper
• Cardiovascular Disease and Its Risk Factors in IDDM in Europe

  1996cited by this paper
• Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group.

  1995cited by this paper
• Quantitative and Qualitative Lipoprotein Abnormalities in Diabetes Mellitus

  1992cited by this paper
• Natural course of insulin resistance in type I diabetes.

  1986cited by this paper
• The changing natural history of nephropathy in type I diabetes.

  1985cited by this paper
• Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

  1983cited by this paper
• Serum Lipids and Lipoproteins in Insulin-treated Diabetes: Demonstration of Increased High Density Lipoprotein Concentrations

  1978cited by this paper

• Remnant Cholesterol: From Pathophysiology to Clinical Implications in Type 1 Diabetes

  2025cites this paper
• Gene Expression in Urinary Sediment Cells as an Indicator of the Contribution of Plasma Lipids to Diabetic Kidney Disease

  2025cites this paper
• Lessons learned from the FinnDiane Study: Epidemiology and metabolic risk factors for diabetic kidney disease in type 1 diabetes

  2024cites this paper
• Glucose control and variability assessed by continuous glucose monitoring in patients with type 1 diabetes and diabetic kidney disease

  2024cites this paper
• A special issue on from bench to bedside: An integrated and multidisciplinary approach to tackling diabetic kidney disease

  2024cites this paper